The nation with a mighty pharmaceutical industry that is known for its reputation of being costeffective in manufacturing, scalable, and taking extreme precautions with biotechnology and generic medicines, India has become a prime destination for the production of oncology drugs. India holds an important position in the world market for oncology drugs, especially generic and bio similar drugs that have been delivering cancer remedies to millions of patients across the globe. The pharmaceutical industry in India is also pretty strong, offering an outstanding number of over 10,000 pharmaceutical companies. The major portion of them is very much engaged in the production of oncology drugs. They produce a wide range of treatments for this overall category of cancer, such as chemotherapy, targeted therapies, immunotherapy, and hormonal therapy. Most of these companies have strived in their R&D, offering innovative drugs that can be used for a wide category of cancers. Largely highlighted amongst these are the cancer of the lung, breast, colon, and prostate, where incidence rates are relatively very high globally.
On such due care and cautious protection the regulatory control mechanisms over the drugs' approval in India exercise, the oncology drugs manufactured there remain one of international safety and efficacy standards. Indian manufacturers have increasingly sought certifications from global regulatory agencies, including...
Our subscribers play a decisive role in finalization of our annual list of Top 10 Oncology Drugs Manufacturers – 2024 by nominating those which have served them with excellence and are praiseworthy. If you feel there is a company that deserves to be on our annual list, do write to us about them mentioning their value proposition.
 | Pfizer | A global biopharmaceutical company that develops, manufactures, and sells medicines, vaccines, and consumer healthcare products, specialise with expert therapy in 4 business categories, Vaccines, Hospitals, Internal Medicine and Inflammation and Immunology |
 | Biocon | A global biopharmaceutical company, focuses on developing new ways to treat cancer, diabetes, and autoimmune diseases, manufactures generic active pharmaceutical ingredients (APIs), biologics, biosimilar insulins, and antibodies |
 | SP Accure Labs | A leading manufacturer with an extensive oncology product portfolio ranging from tablets and capsules to complex formulations such as lyophilized injections, nanoparticles, and liposomes |
 | Merck | A leading science and technology company, operates across healthcare, life science and electronics, committed to developing and delivering breakthrough therapies for patients living with cancer |
 | Roche Diagnostics | A leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas, excellence in innovation, operations and an unwavering commitment to the people and sustainability |
 | Sakar Healthcare | Boasts of over two decades of experience in manufacturing a large variety of pharmaceutical products for key therapeutic areas |
 | Nutraferon Healthcare | Guarantees every batch satisfies the highest quality criteria by using the most recent developments in artificial intelligence and automation, thereby providing confidence in their drugs for patients and clinicians |
 | Cadila Pharmaceuticals | Manufactures and develops affordable medicines, products include active pharmaceutical ingredients (APIs), finished formulations, food supplements, biotechnology products, and pharmaceutical machinery |
 | Decina Pharma | Specialized healthcare designed to promote healing, prevent both acute and chronic skin conditions while simultaneously treating oncological cancers and infectious diseases, a leading provider of high-quality good manufacturing practice (GMP) and compliant active pharmaceutical ingredients APIs |
 | Viviora Lifesciences | The firm manufactures its products primarily in WHO GMP-approved facilities, meeting the minimum standards required by most countries, specializes in exporting oncology, generics, and nutraceuticals, focusing on global healthcare access |
